According to The Cancer Genome Atlas (TCGA) data genomic alterations of TP53 and CDKN2A are found in 15.1% and 13.3% of melanomas respectively [2], and are are frequently co-mutated with BRAF and NRAS mutations. Here, BRAF is linked to melanoma.